Cubist Systematic Strategies’s Allogene Therapeutics ALLO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-82,544
| Closed | -$265K | – | 2186 |
|
|
2023
Q4 | $265K | Sell |
82,544
-131,600
| -61% | -$422K | ﹤0.01% | 1545 |
|
|
2023
Q3 | $679K | Buy |
214,144
+194,241
| +976% | +$616K | 0.01% | 1182 |
|
|
2023
Q2 | $98.9K | Sell |
19,903
-452,739
| -96% | -$2.25M | ﹤0.01% | 1817 |
|
|
2023
Q1 | $2.33M | Buy |
472,642
+183,643
| +64% | +$907K | 0.01% | 1038 |
|
|
2022
Q4 | $1.82M | Sell |
288,999
-290,246
| -50% | -$1.83M | 0.01% | 1375 |
|
|
2022
Q3 | $6.26M | Buy |
579,245
+304,445
| +111% | +$3.29M | 0.04% | 645 |
|
|
2022
Q2 | $3.13M | Buy |
274,800
+68,767
| +33% | +$784K | 0.02% | 1187 |
|
|
2022
Q1 | $1.88M | Buy |
206,033
+65,243
| +46% | +$594K | 0.02% | 1530 |
|
|
2021
Q4 | $2.1M | Buy |
+140,790
| New | +$2.1M | 0.02% | 1321 |
|
|
2021
Q3 | – | Sell |
-124,598
| Closed | -$3.25M | – | 2939 |
|
|
2021
Q2 | $3.25M | Buy |
124,598
+96,497
| +343% | +$2.52M | 0.04% | 787 |
|
|
2021
Q1 | $992K | Sell |
28,101
-84,220
| -75% | -$2.97M | 0.01% | 1542 |
|
|
2020
Q4 | $2.84M | Buy |
+112,321
| New | +$2.84M | 0.04% | 748 |
|
|
2020
Q3 | – | Sell |
-11,943
| Closed | -$511K | – | 2473 |
|
|
2020
Q2 | $511K | Sell |
11,943
-2,069
| -15% | -$88.5K | 0.01% | 1577 |
|
|
2020
Q1 | $272K | Sell |
14,012
-24,821
| -64% | -$482K | 0.01% | 1571 |
|
|
2019
Q4 | $1.01M | Buy |
+38,833
| New | +$1.01M | 0.02% | 1153 |
|